Summary
Guardant Health, Inc. (GH) filed an 8-K on May 7, 2026, to report its financial results for the fiscal quarter ended March 31, 2026. The press release, furnished as Exhibit 99.1, provides the key financial and operational data investors need to assess the company's performance. Investors should review this press release for details on revenue, profitability, cash flow, and any forward-looking guidance. While specific financial figures are not detailed within the 8-K itself, the filing serves as the official channel for disseminating this crucial information. The incorporation by reference of the press release means that all information contained within it is considered part of the company's public disclosures. Investors are advised to access Exhibit 99.1 directly for a comprehensive understanding of Guardant Health's first-quarter 2026 performance and its implications for future growth and market position.
Key Highlights
- 1Guardant Health announced first-quarter 2026 financial results on May 7, 2026, via an 8-K filing.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing detailed financial and operational information.
- 3Investors should refer to the furnished press release for specific performance metrics.
- 4The filing is intended to inform stakeholders about the company's financial condition and results of operations.
- 5The information furnished is not considered 'filed' for Section 18 purposes but is incorporated by reference into relevant securities filings.